title: [Raising HDL cholesterol: which is the best strategy?].
abstract: After having reached the objective for the LDL cholesterol levels, it becomes imperative to reach the objective for HDL cholesterol, known for its anti-atherogenic properties, generally confirmed in many epidemiological studies. This review deals, in a clear and concise manner, with the different alternatives available in daily clinical practice to raise the HDL cholesterol levels of patients, to achieve better outcomes in terms of morbidity and mortality in cardiovascular disease.
authors: División de Lípidos y Diabetes, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia. jefelicianoa@yahoo.com
authors: John Edwin Feliciano
authors: JE
authors: Alfonso
authors: Iván Darío Sierra
authors: ID
authors: Ariza
mesh_terms: D002318:Cardiovascular Diseases / Q000378:metabolism / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000378:metabolism; D002995:Clofibric Acid / Q000627:therapeutic use; D015444:Exercise; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D015201:Meta-Analysis as Topic; D009525:Niacin / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D000077285:Rimonabant; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D045162:Thiazolidinediones / Q000627:therapeutic use
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D010880:Piperidines; D011720:Pyrazoles; D045162:Thiazolidinediones; D009525:Niacin; D002995:Clofibric Acid; D000077285:Rimonabant